Notice about cookies

Close

This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy. By clicking Accept below or continuing to use this website (including closing this message), you confirm that you have read and consent to our use of cookies as detailed in our Cookie Policy.

Accept

UCB's Global Corporate Website
Welcome to UCB in the United States

U.S. Leadership Team

Emmanuel Caeymaex

Headshot of Emmanuel Caeymaex, Executive Vice President, Immunology and U.S. Solutions
<nolink>

Executive Vice President, Immunology and U.S. Solutions

Brad Chapman

Brad Chapman

Head, U.S. Epilepsy and Rare Syndromes

Anisa Dhalla

Headshot of Anisa Dhalla, Chief Ethics and Compliance Officer
Anisa Dhalla

Chief Ethics and Compliance Officer

Brandon Drew

Brandon Drew

Head, U.S. Insights to Impact

Patty Fritz

Headshot of Patty Fritz, Head, U.S. Corporate Affairs
Patty Fritz

Head, U.S. Corporate Affairs

Camille Lee

Headshot of Camille Lee, Head, U.S. Immunology
Camille Lee

Head, U.S. Immunology

Simon Lemmy

Simon Lemmy

U.S. Talent Partner Lead

Kim Moran

Headshot of Kim Moran, Head, U.S. Insights to Impact
Kim Moran

Head, U.S. Rare Disease

Jeremy Schafer

<nolink>

Head, U.S. Payer Value Strategy, and Innovation

Jane Thompson

Headshot of Jane Thompson, Head, U.S. Market Access Account Management
<nolink>

Head, U.S. Market Access Account Management

EXECUTIVE COMMITTEE
UCB IN THE U.S.
LATEST NEWS

© 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
USPR-CORP-0115-00003(2)